The European Medicines Agency’s Pharmacovigilance Risk Committee (PRAC) has agreed on a direct healthcare professional communication (DHPC) to remind healthcare professionals that extreme caution ...
South Korea-based Celltrion today announced that the US Food and Drug Administration (FDA) has designated Stoboclo (denosumab-bmwo) and Osenvelt (denosumab-bmwo) as interchangeable biosimilars to the ...
US anti-virals giant Gilead Sciences late yesterday announced its third quarter 2025 results of operations, reporting total ...
US biotech 4D Molecular Therapeutics (Nasdaq: FDMT) has granted Japan’s Otsuka Pharmaceutical (TYO: 4578) exclusive rights to ...
King Faisal Specialist Hospital & Research Centre (KFSHRC) has begun in-house manufacturing and clinical use of CAR-T cell ...
The top 20 global biopharmaceutical companies saw their combined market capitalization rise 4% in the third quarter of 2025 ...
Merck & Co (NYSE: MRK) posted third-quarter 2025 revenue of $17.3 billion, up 4% year over year, while adjusted earnings rose ...
German family-owned pharma major Boehringer Ingelheim has licensed a pre-clinical program from Japan’s Kyowa Kirin to develop ...
The US Health Resources and Services Administration (HRSA) has approved nine drugs for a pilot testing a new rebate model ...
Swiss pharma major Roche (ROG: SIX) has entered a global exclusive licensing agreement with China’s Qyuns Therapeutics for ...
An Austrian biotech company developing protein-conjugation technologies aimed at accelerating vaccine and therapeutic ...
Swiss pharma giant Novartis today presented new ianalumab data in Sjögren’s disease, the second most prevalent rheumatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback